Physician profile
Michael Younes
NPI 1760469688
$34,110.17
in general payments reported to CMS, 2019-2025
26 companies · $1,878 in 2025
The $1,878 reported for 2025 was more than what 82% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $389 · 2020: $513 · 2021: $3,482 · 2022: $3,072 · 2023: $6,609 · 2024: $18K · 2025: $1,878.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $19K · Travel and Lodging: $4,802 · Food and Beverage: $2,853.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $19,000.00 |
| Travel and Lodging | $4,802.41 |
| Food and Beverage | $2,852.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| International Life Sciences | $21,084.99 | 2023-2024 | Flexband |
| Novus Surgical Solutions LLC | $3,434.05 | 2021-2022 | |
| Arthrex, INC. | $3,074.43 | 2021-2025 | |
| Novus Surgical Consultants | $2,516.91 | 2023-2025 | |
| Stryker Corporation | $2,070.50 | 2020-2025 | Augment Injectable, Ortholoc 2 Lapifuse, Hoffmann |
| Organogenesis INC. | $321.21 | 2019-2025 | Simplimax, Cygnus Dual |
| Wright Medical Technology, INC. | $254.15 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $185.84 | 2019-2020 | |
| Averitas Pharma INC. | $182.76 | 2023-2024 | Qutenza |
| Grt US Holding, INC. | $168.19 | 2020-2022 | |
| Abbott Laboratories | $142.24 | 2023 | Proclaim |
| Trimed, INC. | $113.61 | 2023 | |
| Smith+Nephew, INC. | $97.33 | 2019-2024 | Collagenase Santyl, Regranex |
| Merck Sharp & Dohme LLC | $93.61 | 2019 | |
| Exactech, INC. | $80.00 | 2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $63.02 | 2024 | |
| Novastep INC. | $53.21 | 2021-2022 | |
| Heron Therapeutics, INC. | $33.10 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $31.73 | 2023 | Seglentis |
| Vertex Pharmaceuticals Incorporated | $22.81 | 2025 | |
| Alfasigma USA, INC. | $15.90 | 2021 | |
| Bioventus LLC | $15.02 | 2024 | Exogen Ultrasound Bone Healing System |
| Treace Medical Concepts, INC. | $15.00 | 2022 | |
| Paragon 28, INC. | $14.73 | 2023 | Phantom Metatarsal Shortening |
| Pfizer INC. | $13.58 | 2019 | |
| Zyla Life Sciences, INC. | $12.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Younes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.